Golden State Wealth Management LLC acquired a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 539 shares of the financial services provider’s stock, valued at approximately $44,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in MET. CWM LLC increased its stake in shares of MetLife by 15.0% in the 3rd quarter. CWM LLC now owns 18,256 shares of the financial services provider’s stock valued at $1,506,000 after acquiring an additional 2,383 shares during the last quarter. Ritholtz Wealth Management bought a new stake in MetLife in the third quarter valued at approximately $214,000. Carnegie Investment Counsel raised its holdings in MetLife by 8.9% in the third quarter. Carnegie Investment Counsel now owns 6,031 shares of the financial services provider’s stock worth $497,000 after purchasing an additional 494 shares during the period. Sound Income Strategies LLC boosted its position in shares of MetLife by 98.3% during the third quarter. Sound Income Strategies LLC now owns 712 shares of the financial services provider’s stock worth $59,000 after purchasing an additional 353 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of MetLife by 54.5% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 757 shares of the financial services provider’s stock valued at $62,000 after buying an additional 267 shares during the period. Institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Wells Fargo & Company cut their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Finally, Barclays dropped their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $91.08.
MetLife Trading Up 0.2 %
Shares of NYSE:MET opened at $83.24 on Wednesday. The company’s 50-day moving average price is $83.64 and its two-hundred day moving average price is $80.93. MetLife, Inc. has a one year low of $67.04 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $57.64 billion, a PE ratio of 13.94, a price-to-earnings-growth ratio of 0.64 and a beta of 1.07.
MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities analysts forecast that MetLife, Inc. will post 9.63 EPS for the current fiscal year.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.62%. MetLife’s payout ratio is 36.52%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Stock Analyst Ratings and Canadian Analyst Ratings
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Invest in the FAANG Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.